What is the market doing?
What the tape says about SUPN
Supernus Pharmaceuticals, Inc. is −1.3% over the past year while the S&P 500 is +20%: 22 points behind the market.
−1.3%
1-year return · S&P 500 +20%
- vs 200-day average
- −13%
vs 200-day average · a clear downtrend
- RSI (14)
- 19
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 26%
Below its 52-week high
Details›
- Last close2026-09-08
- $42.43
- 1 monthS&P 500 −0.30%
- −9.3%
- 1 yearS&P 500 +20%
- −1.3%
- 5 yearsS&P 500 +85%
- +73%
- vs 50-day average$46.00
- −7.8%
- 52-week high
- $57.00
- 52-week low
- $42.00
- Annualised volatility
- 36%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.8M
| Year | Return |
|---|---|
| 2026 (year to date) | −15% |
| 2025 | +37% |
| 2024 | +25% |
| 2023 | −19% |
| 2022 | +22% |
| 2021 | +16% |
| 2020 | +6.1% |
| 2019 | −29% |
| 2018 | −17% |
| 2017 | +58% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +5.3% |
| Feb | 10 | 4 of 10 | −2.8% |
| Mar | 10 | 5 of 10 | +3.2% |
| Apr | 10 | 6 of 10 | +2.6% |
| May | 10 | 3 of 10 | −0.79% |
| Jun | 10 | 5 of 10 | +2.2% |
| Jul | 11 | 7 of 11 | +1.2% |
| Aug | 11 | 6 of 11 | +2.6% |
| Sep | 11 | 4 of 11 | −1.3% |
| Oct | 10 | 6 of 10 | −0.79% |
| Nov | 10 | 6 of 10 | +1.1% |
| Dec | 10 | 6 of 10 | +2.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #11 of 29 by Smart Score